HalioDx is an immuno-oncology diagnostic company providing oncologists with first-in-class, immune-based diagnostic products and services to guide cancer care and contribute to precision medicine. HalioDx collaborates with renowned international clinical groups to support clinical utility and ensure rigorous performance validation of its assays in selected cancer indications. HalioDx also develops assays such as Halioseek® and Immunosign® to help stratifying patients for immunotherapies.